Lipophytol® is the ideal ingredient to create Cardiovascular Nutraceuticals that work. And in Heart Month we want to tell you much more about this incredible ingredient from Lubrizol.
Heart Month, also known as Heart Health Awareness Month, is celebrated in February in many countries, including the United States.
The main objective of this celebration is to raise awareness about the importance of cardiovascular health and educate people on ways to prevent heart disease, which is one of the main causes of death in the world.
That is why we share with you the following video where Isabel Gómez from Lubrizol helps us understand why Lipophytol is the ideal ingredient to formulate nutraceuticals in this category.
Lipophytol: Innovation in Cardiovascular Health
Lipophytol is an advanced microencapsulated ingredient derived from phytosterols and omega-3s specifically selected and processed to maximize their bioavailability and cardiovascular efficacy. This innovative compound is obtained through a patented process that combines:
- Phytosterols extracted from select vegetable oils
- High purity omega-3 fatty acids (EPA and DHA)
- Natural antioxidants for stabilization
What is the Origin and Development?
The development of Lipophytol represents a significant innovation in the field of cardiovascular nutraceuticals. Its unique formulation is based on:
Premium raw material selection:
- First cold-pressed vegetable oils
- Deep-sea fish for omega-3
- Natural antioxidants from botanical sources
The European Food Safety Authority (EFSA) has approved the following claims about phytosterols:
Phytosterols have been shown to reduce blood cholesterol with a daily intake of 1.5-2.4 g of phytosterols/stanols.
Phytosterols/stanols contribute to the maintenance of normal blood cholesterol levels with a daily intake of 0.8 g of phytosterols/stanols.
The U.S. Food and Drug Administration (FDA) has approved the following claim for phytosterols: “Foods containing at least 0.4 grams per serving of phytosterols, consumed twice daily with meals for a daily total of at least 0.8 grams, as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease.”
Due to their insolubility in water and lipids,la incorporación de fitoesteroles en alimentos y bebidas ha sido un desafío. En este sentido, nuestra formulación facilita la incorporación de fitoesteroles en matrices alimentarias gracias a su alta dispersibilidad.
Proven Benefits for the Heart
- Improves Cholesterol Levels
- Reduction of LDL (bad) cholesterol
- Lowers cholesterol by an average of 15-20%
- Prevents the intestine from absorbing so much cholesterol
- Increases the elimination of cholesterol through bile
Increase in HDL (good) cholesterol:
- Increases cholesterol by an average of 8-12%
- Improves cholesterol transport back to the liver
- Optimizes HDL function
Blood Pressure Control:
- Average reduction in systolic pressure by 8-12 mmHg
- Average reduction in diastolic pressure by 5-8 mmHg
They can be incorporated into dairy products, yogurts, soy drinks, rye bread, cheese-type products, dietary supplements, among others.
Do you want to Contact Lubrizol?
Request more information by completing the following form here
What is Cardiovascular Health?
Cardiovascular health refers to the optimal state of the heart, blood vessels, and circulatory system in general. It involves:
The efficient functioning of the heart as a pump
The health of the arteries and veins
Adequate blood circulation
The maintenance of healthy blood pressure levels
An adequate balance of lipids in the bloodWhat Shocking Statistics Are There?
Cardiovascular diseases cause 18.6 million deaths a year
They account for 32% of all deaths worldwide
They disproportionately affect low- and middle-income countries (75% of deaths)What is the Economic Impact of cardiovascular health problems?
Estimated annual global cost: $863 billion (2020)
Direct medical expenses: 58% of total cost
Loss of productivity: 42% of total costHow does it impact people’s Quality of Life?
Average reduction of 12 years in life expectancy
Significant decrease in work capacity
68% increase in the risk of depression
Limitations in daily activities in 60% of patients
